Cost-effectiveness of care for patients with type 2 diabetes, an evaluation of an innovative shared diabetes care model (WC2004-045)


Starting date: 01/09/2006 Evaluation diabetes care
In Amstelland, the implemented diabetes care consists of among others, structured care achieved by the use of a central database, a coordinating role for the diabetes nurse and an active recall system. 
In West-Friesland, patients receive care by the Diabetes Care System West-Friesland (DCS) in addition to the care delivered by their own general practitioner. Patients receive their annual medical check-up in this specialized diabetes centre, in combination with education and self-management support. The Diabetes Care System coordinates the care and offers feedback to the general practitioner regarding patient outcomes. 
The control group consists of patients of GP's who are affiliated to the NIVEL's "CMR-Peilstations", and patients of GP’s, located in West-Friesland, who do not receive care by the Diabetes Care system. Diabetes patients in the control group will receive the current usual diabetes care.

The MICADO model
We are developing the MICADO model for the purpose of evaluating the long term cost-effectiveness of interventions in diabetes patients and in the general population.
The MICADO model is a markov-type, multistate transition model which is set up to estimate long term microvascular and macrovascular complications of type 1 and type 2 diabetes. The MICADO model has elaborate modeling of complications and gives outcomes in terms of complications, quality of life, costs and cost-effectiveness. It is capable of evaluating interventions targeting diabetes patients as well as prevention programs in a general population and comparing these.